These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26428455)

  • 1. Optimal attenuation of a PR8-derived mouse pathogenic H5N1 recombinant virus for testing antigenicity and protective efficacy in mice.
    Kim IH; Kwon HJ; Park JK; Song CS; Kim JH
    Vaccine; 2015 Nov; 33(46):6314-9. PubMed ID: 26428455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimized clade 2.3.2.1c H5N1 recombinant-vaccine strains against highly pathogenic avian influenza.
    Jang JW; Lee CY; Kim IH; Choi JG; Lee YJ; Yuk SS; Lee JH; Song CS; Kim JH; Kwon HJ
    J Vet Sci; 2017 Aug; 18(S1):299-306. PubMed ID: 28859269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NA proteins of influenza A viruses H1N1/2009, H5N1, and H9N2 show differential effects on infection initiation, virus release, and cell-cell fusion.
    Chen Q; Huang S; Chen J; Zhang S; Chen Z
    PLoS One; 2013; 8(1):e54334. PubMed ID: 23349854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
    Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
    Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avian-derived NS gene segments alter pathogenicity of the A/Puerto Rico/8/34 virus.
    Park SJ; Lee EH; Choi EH; Pascua PN; Kwon HI; Kim EH; Lim GJ; Decano A; Kim SM; Choi YK
    Virus Res; 2014 Jan; 179():64-72. PubMed ID: 24269912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant.
    Sui Z; Chen Q; Wu R; Zhang H; Zheng M; Wang H; Chen Z
    Arch Virol; 2010 Apr; 155(4):535-44. PubMed ID: 20195654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the antigenic relatedness and cross-protective immunity of the neuraminidase between human influenza A (H1N1) virus and highly pathogenic avian influenza A (H5N1) virus.
    Lu X; Liu F; Zeng H; Sheu T; Achenbach JE; Veguilla V; Gubareva LV; Garten R; Smith C; Yang H; Stevens J; Xu X; Katz JM; Tumpey TM
    Virology; 2014 Apr; 454-455():169-75. PubMed ID: 24725943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virulence determinants in the PB2 gene of a mouse-adapted H9N2 virus.
    Liu Q; Huang J; Chen Y; Chen H; Li Q; He L; Hao X; Liu J; Gu M; Hu J; Wang X; Hu S; Liu X; Liu X
    J Virol; 2015 Jan; 89(1):877-82. PubMed ID: 25339773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A live bivalent influenza vaccine based on a H9N2 virus strain.
    Wu R; Guan Y; Yang Z; Chen J; Wang H; Chen Q; Sui Z; Fang F; Chen Z
    Vaccine; 2010 Jan; 28(3):673-80. PubMed ID: 19892041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reassortment and modification of hemagglutinin cleavage motif of avian/WSN influenza viruses generated by reverse genetics that correlate with attenuation.
    Lu JH; Long JX; Jia LJ; Liu YL; Shao WX; Zhang YM; Liu XF
    Acta Virol; 2006; 50(4):243-9. PubMed ID: 17177609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protection.
    Patel A; Gray M; Li Y; Kobasa D; Yao X; Kobinger GP
    Vaccine; 2012 Jan; 30(3):626-36. PubMed ID: 22119588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse lung-adapted mutation of E190G in hemagglutinin from H5N1 influenza virus contributes to attenuation in mice.
    Han P; Hu Y; Sun W; Zhang S; Li Y; Wu X; Yang Y; Zhu Q; Jiang T; Li J; Qin C
    J Med Virol; 2015 Nov; 87(11):1816-22. PubMed ID: 26089289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathogenicity of swan derived H5N1 virus in birds and mammals and its gene analysis.
    Tabynov K; Sansyzbay A; Sandybayev N; Mambetaliyev M
    Virol J; 2014 Nov; 11():207. PubMed ID: 25471127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans.
    Sandbulte MR; Jimenez GS; Boon AC; Smith LR; Treanor JJ; Webby RJ
    PLoS Med; 2007 Feb; 4(2):e59. PubMed ID: 17298168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model.
    Ninomiya A; Imai M; Tashiro M; Odagiri T
    Vaccine; 2007 May; 25(18):3554-60. PubMed ID: 17293015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the internal genes of influenza A (H7N9) virus contributing to high pathogenicity in mice.
    Bi Y; Xie Q; Zhang S; Li Y; Xiao H; Jin T; Zheng W; Li J; Jia X; Sun L; Liu J; Qin C; Gao GF; Liu W
    J Virol; 2015 Jan; 89(1):2-13. PubMed ID: 25320305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a dual-protective live attenuated vaccine against H5N1 and H9N2 avian influenza viruses by modifying the NS1 gene.
    Choi EH; Song MS; Park SJ; Pascua PN; Baek YH; Kwon HI; Kim EH; Kim S; Jang HK; Poo H; Kim CJ; Choi YK
    Arch Virol; 2015 Jul; 160(7):1729-40. PubMed ID: 25959557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycine at Position 622 in PB1 Contributes to the Virulence of H5N1 Avian Influenza Virus in Mice.
    Feng X; Wang Z; Shi J; Deng G; Kong H; Tao S; Li C; Liu L; Guan Y; Chen H
    J Virol; 2016 Feb; 90(4):1872-9. PubMed ID: 26656683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivated and adjuvanted whole-virion clade 2.3.4 H5N1 pre-pandemic influenza vaccine possesses broad protective efficacy against infection by heterologous clades of highly pathogenic H5N1 avian influenza virus in mice.
    Harada Y; Ninomiya-Mori A; Takahashi Y; Shirakura M; Kishida N; Kageyama T; Tada Y; Tashiro M; Odagiri T
    Vaccine; 2011 Oct; 29(46):8330-7. PubMed ID: 21911027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the phylogeny of Chinese H9N2 avian influenza viruses and their pathogenicity in mice.
    Lin Z; Xu C; Liu B; Ji Y; Fu Y; Guo J; Zhu Q
    Arch Virol; 2014 Oct; 159(10):2575-86. PubMed ID: 24838853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.